DE602006020688D1 - Verfahren zum nachweis oder zur überwachung einer bösartigen plasmazellkrankheit - Google Patents

Verfahren zum nachweis oder zur überwachung einer bösartigen plasmazellkrankheit

Info

Publication number
DE602006020688D1
DE602006020688D1 DE602006020688T DE602006020688T DE602006020688D1 DE 602006020688 D1 DE602006020688 D1 DE 602006020688D1 DE 602006020688 T DE602006020688 T DE 602006020688T DE 602006020688 T DE602006020688 T DE 602006020688T DE 602006020688 D1 DE602006020688 D1 DE 602006020688D1
Authority
DE
Germany
Prior art keywords
detecting
immunoglobulins
bound
monitoring
plasma cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602006020688T
Other languages
German (de)
English (en)
Inventor
Arthur Randell Bradwell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Binding Site Group Ltd
Original Assignee
Binding Site Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Binding Site Group Ltd filed Critical Binding Site Group Ltd
Publication of DE602006020688D1 publication Critical patent/DE602006020688D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57505—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the blood, e.g. leukaemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602006020688T 2005-01-27 2006-01-26 Verfahren zum nachweis oder zur überwachung einer bösartigen plasmazellkrankheit Expired - Lifetime DE602006020688D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0501741.3A GB0501741D0 (en) 2005-01-27 2005-01-27 Antibody
PCT/GB2006/000267 WO2006079816A1 (en) 2005-01-27 2006-01-26 Method of detecting or monitoring a malignant plasma cell disease

Publications (1)

Publication Number Publication Date
DE602006020688D1 true DE602006020688D1 (de) 2011-04-28

Family

ID=34259791

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006020688T Expired - Lifetime DE602006020688D1 (de) 2005-01-27 2006-01-26 Verfahren zum nachweis oder zur überwachung einer bösartigen plasmazellkrankheit

Country Status (11)

Country Link
US (3) US7897353B2 (https=)
EP (2) EP1842071B3 (https=)
JP (3) JP5431674B2 (https=)
AT (1) ATE502302T1 (https=)
DE (1) DE602006020688D1 (https=)
DK (1) DK2306202T3 (https=)
ES (2) ES2455440T3 (https=)
GB (1) GB0501741D0 (https=)
PL (1) PL2306202T3 (https=)
PT (1) PT2306202E (https=)
WO (1) WO2006079816A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0608444D0 (en) 2006-04-27 2006-06-07 Binding Site The Ltd Dialysis
GB0801609D0 (en) * 2008-01-29 2008-03-05 Binding Site The Ltd Hevylite diagnostic stain
WO2010120561A1 (en) 2009-04-01 2010-10-21 Genentech, Inc. Anti-fcrh5 antibodies and immunoconjugates and methods of use
GB0914535D0 (en) * 2009-08-19 2009-09-30 Binding Site Group The Ltd Prognosis assay
GB201001946D0 (en) * 2010-02-05 2010-03-24 Binding Site Group The Ltd Cancer prognostic assay
GB201001950D0 (en) * 2010-02-05 2010-03-24 Binding Site Group The Ltd Infection prognostic assay
GB201012049D0 (en) * 2010-07-19 2010-09-01 Binding Site Group The Ltd Competition assay
GB201203938D0 (en) * 2012-03-06 2012-04-18 Binding Site Group The Ltd Assay system
ES2702183T3 (es) * 2013-03-15 2019-02-27 Mayo Found Medical Education & Res Identificación y monitorización de inmunoglobulinas monoclonales por masa molecular
DE112014004109B4 (de) 2013-09-06 2021-05-20 Sensor Electronic Technology Inc. Diffuse Ultraviolettbeleuchtung
WO2015154052A1 (en) 2014-04-04 2015-10-08 Mayo Foundation For Medical Education And Research Isotyping immunoglobulins using accurate molecular mass
GB201511364D0 (en) * 2015-06-29 2015-08-12 Binding Site Group The Ltd Method of detecting or monitoring an IgG4-related disease
GB2541027A (en) * 2015-08-07 2017-02-08 The Binding Site Group Ltd Treatment
GB201603291D0 (en) * 2016-02-25 2016-04-13 Binding Site Group The Ltd Antibodies
EP3681907A4 (en) 2017-09-13 2021-07-07 Mayo Foundation for Medical Education and Research IDENTIFICATION AND MONITORING OF IMMUNOGLOBULIN J-CHAINS
WO2019055634A1 (en) 2017-09-13 2019-03-21 Mayo Foundation For Medical Education And Research IDENTIFICATION AND MONITORING OF A MACROPHAGE APOPTOSIS INHIBITOR
WO2021202992A2 (en) * 2020-04-03 2021-10-07 Lawrence Loomis Rapid point of care assay for the detection of the asymptomatic carrier state of covid-19
GB202007047D0 (en) * 2020-05-13 2020-06-24 Binding Site Group Ltd Mass spectrometry controls

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3907502A (en) 1973-12-11 1975-09-23 Miless L Brink Method for identifying Bence Jones proteins
EP0044219A1 (en) 1980-07-16 1982-01-20 Unilever Plc Methods of immuno analysis using monoclonal antibodies
JPS63139199A (ja) * 1986-12-01 1988-06-10 Wakunaga Pharmaceut Co Ltd 抗ヒトＩｇＥモノクロ−ナル抗体及びその用途
ATE195022T1 (de) 1987-04-27 2000-08-15 Unilever Nv Spezifische bindungstestverfahren
US4983530A (en) * 1988-01-29 1991-01-08 E. I. Du Pont De Nemours And Company Sandwich immunoassay for determination of total monoclonal IGG
US5185066A (en) * 1988-08-11 1993-02-09 Helena Laboratories Corporation Immunofixation electrophoresis control system
JPH03199966A (ja) * 1989-12-27 1991-08-30 Kazutomo Wakasugi 遊離型ｌ鎖の測定方法
JPH04262792A (ja) * 1990-01-12 1992-09-18 Takeda Chem Ind Ltd 蛋白質の精製法
US5228960A (en) * 1992-07-17 1993-07-20 Beckman Instruments, Inc. Analysis of samples by capillary electrophoretic immunosubtraction
US5552277A (en) * 1994-07-19 1996-09-03 The Johns Hopkins University School Of Medicine Genetic diagnosis of prostate cancer
EP0862584B1 (en) * 1995-11-03 2004-12-22 The Binding Site Limited Production of antibodies
GB9718911D0 (en) * 1997-09-05 1997-11-12 Orion Yhtymae Oy Monoclonal antibodies
EP1131344B1 (en) * 1998-11-19 2005-08-03 ELAN CORPORATION, Plc Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
US20040163137A1 (en) * 2001-02-20 2004-08-19 Caroline Barry PG-3 and biallelic markers thereof
US20020182748A1 (en) 2001-03-30 2002-12-05 Reardon Paul C. Method and device for testing for Bence-Jones Protein
US20050154192A1 (en) * 2001-11-27 2005-07-14 Kamon Shirakawa Anti-il13 receptor alpha1 neutralizing antibody
US20040018576A1 (en) 2002-07-24 2004-01-29 Dematteo Todd M. Bence Jones protein testing cassette
CA2515699C (en) * 2003-02-10 2015-01-27 Aya Jakobovits Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
AU2004213053C1 (en) * 2003-02-20 2009-07-16 Seagen Inc. Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
EP1613658B1 (en) * 2003-04-02 2012-03-14 F. Hoffmann-La Roche AG Antibodies against insulin-like growth factor i receptor and uses thereof
WO2005062044A1 (ja) * 2003-11-19 2005-07-07 Yamasa Corporation ベンスジョーンズ蛋白質の検定法
JP4438455B2 (ja) * 2004-03-04 2010-03-24 ヤマサ醤油株式会社 遊離ヒトイムノグロブリン軽鎖の測定法及びキット
WO2005116651A2 (en) * 2004-05-24 2005-12-08 Diasys Corporation Method and device for testing for bence-jones protein

Also Published As

Publication number Publication date
ATE502302T1 (de) 2011-04-15
US8592561B2 (en) 2013-11-26
JP2013147499A (ja) 2013-08-01
EP1842071A1 (en) 2007-10-10
EP1842071B3 (en) 2014-02-26
ES2455440T3 (es) 2014-04-15
GB0501741D0 (en) 2005-03-02
WO2006079816A1 (en) 2006-08-03
JP2008528995A (ja) 2008-07-31
EP2306202A1 (en) 2011-04-06
DK2306202T3 (da) 2014-02-10
US20110177535A1 (en) 2011-07-21
US20080166742A1 (en) 2008-07-10
US8415110B2 (en) 2013-04-09
JP6007134B2 (ja) 2016-10-12
EP2306202B1 (en) 2013-12-18
EP1842071B1 (en) 2011-03-16
ES2365626T7 (es) 2014-06-04
PL2306202T3 (pl) 2014-05-30
PT2306202E (pt) 2014-02-27
ES2365626T3 (es) 2011-10-07
US20110177977A1 (en) 2011-07-21
US7897353B2 (en) 2011-03-01
JP2014025950A (ja) 2014-02-06
JP5431674B2 (ja) 2014-03-05
JP5715671B2 (ja) 2015-05-13

Similar Documents

Publication Publication Date Title
DE602006020688D1 (de) Verfahren zum nachweis oder zur überwachung einer bösartigen plasmazellkrankheit
ATE410684T1 (de) Molekular-modifikations-assays
CA2548164A1 (en) Assay kit for detecting analytes of interest in samples
DE60334029D1 (de) Hochempfindliche assays für die pathogendetektion unterverwendung der metallverstärkten fluoreszenz
WO2011056185A3 (en) Reactivity-dependent and interaction-dependent pcr
WO2009058902A3 (en) Methods and devices for analyte detection
ATE532830T1 (de) Langwellige thiolgruppenreaktive fluorophore
WO2010049672A3 (en) Methods and products for measuring free immunoglobulin light chain molecules
WO2007035633A3 (en) Screening assays and methods
NZ603492A (en) Humanized anti-factor d antibodies and uses thereof
WO2009117510A3 (en) Multi-wavelength analyses of sol-particle specific binding assays
WO2008118558A3 (en) Improved antibody profiling sensitivity through increased reporter antibody layering
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
WO2008021803A3 (en) Merge stop gate for an automated laboratory sample handling worksystem
ATE516501T1 (de) Verfahren für die fluoreszenz-detektion einer substanz
EP1978366A4 (en) FLUORESCENT MARKER FOR BIOLOGICAL MATERIAL AND METHOD FOR MARKING BIOLOGICAL MATERIAL WITH FLUORESCENCE MARKER
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
WO2010006201A3 (en) Methods of reducing non-specific interaction in metal nanoparticle assays
ATE511650T1 (de) Verfahren zum nachweis von antikörpern einer bestimmten klasse über einen immunkomplex spezifischen antikörper
AR074655A1 (es) Metodos para la clasificacion y el diagnostico de escoliosis
WO2008081331A3 (en) Enhancing the level of antibody expression by framework re-engineering
ATE513215T1 (de) Monoklonale antikörper, hybridomzellinien, verfahren und kits zum nachweis von phytase
DE602005027127D1 (de) Nachweis eines therapeutischen antikörpers in einem versuchstier
DE60323105D1 (de) Verfahren zur beseitigung von störungen in immunochromatographischen assays
WO2006103450A3 (en) Electrochemical assay